Mediconsult Oy
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Mediconsult Oy - overview
Established
1975
Location
Helsinki, -, Finland
Primary Industry
Healthcare IT
About
Mediconsult Oy is a Finnish company specializing in IT solutions for the healthcare and social sectors, providing integrated systems to enhance service delivery and information management for professionals. Founded in 1975, Mediconsult Oy operates from Helsinki, Finland, focusing on IT solutions tailored for healthcare. The company has undergone strategic shifts to enhance its offerings in response to sector needs. Mediconsult has completed one deal, with the latest funding round occurring on December 17, 2020, when Juuri Partners invested an undisclosed amount for a minority stake.
Mediconsult Oy specializes in providing comprehensive IT solutions tailored specifically for the social and healthcare sectors. The company's flagship product, Mediconsult Saga®, is an integrated client and patient information system that encompasses a wide range of functionalities needed to support both social welfare and healthcare services. It includes modular offerings such as Saga Sosiaalihuolto for social welfare services, Saga Terveydenhuolto for healthcare management, and additional systems for home care and rehabilitation services. These solutions are utilized by social and healthcare professionals to enhance the welfare of over one million Finns, addressing critical needs for seamless information sharing and efficient service delivery.
Mediconsult's products primarily serve public and private healthcare organizations across Finland, with a growing presence in international markets, notably in Sri Lanka. Mediconsult Oy reported a revenue of EUR 19. 06 mn for the year 2023, driven by its focus on the healthcare IT sector. The revenue model is largely based on subscription services for the various modules of the Mediconsult Saga® system, allowing for tailored pricing to meet the needs of diverse healthcare organizations.
Additionally, the company engages in partnerships for customized service configurations, with revenue generated from ongoing service agreements and annual audits, emphasizing quality and compliance in service delivery. Mediconsult Oy plans to expand its product offerings, with new modules for emerging healthcare needs set to launch by the end of 2024. The company aims to penetrate additional markets, particularly in Southeast Asia, with targeted expansion efforts to begin in 2025. Recent funding from Juuri Partners will be utilized to support the development of these new products and facilitate market entry strategies, enhancing Mediconsult's competitive position in the global healthcare IT landscape.
Current Investors
Juuri Partners
Primary Industry
Healthcare IT
Sub Industries
Consulting Services, Education & Training Website, Healthcare IT, Medical Software
Website
www.mediconsult.fi
Verticals
HealthTech
Company Stage
Mature - Growth Capital
Total Amount Raised
Subscriber access only
Mediconsult Oy - financials
| Fiscal Year Ended | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue (USD) | 4,254,580.4 | 10,541,390 | 12,729,370.8 | 14,689,411.4 | - | - | - |
| % Revenue Growth (YoY) | - | 147.8% | 20.8% | 15.4% | - | - | - |
| EBITDA (USD) | (922,764.2) | 1,205,657.4 | 835,212 | 540,017.1 | - | - | - |
| Operating Income (USD) | (979,327.5) | 1,016,288.2 | 496,149.8 | (213,710.3) | - | - | - |
| Operating Margin | (23.0%) | 9.6% | 3.9% | (1.5%) | - | - | - |
| % EBITDA Margin | (21.7%) | 11.4% | 6.6% | 3.7% | - | - | - |
| NET Income (USD) | (979,613.6) | 1,015,881.8 | 386,113.4 | (197,497.4) | - | - | - |
| % Net Margin | (23.0%) | 9.6% | 3.0% | (1.3%) | - | - | - |
Mediconsult Oy - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth | Completed | Mediconsult Oy | - |
Displaying 1 - 1 of 1
Mediconsult Oy - key contacts
| Name | Position | Start Date | End Date | Vcard | Bio | ||
|---|---|---|---|---|---|---|---|
| Board Member | BM |
BM Board Member
Want to see more?
Request a demo for full access to this profile

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.